Wells Fargo & Company 180 Life Sciences Corp. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.12 - $1.31 $1 - $17	13 Added 8.13%	173 $0
Q2 2022 Aug 12, 2022	BUY	$0.81 - $2.53 $10 - $32	13 Added 8.84%	160 $0
Q1 2022 May 16, 2022	BUY	$2.53 - $3.9 $5 - $7	2 Added 1.38%	147 $0
Q4 2021 Feb 14, 2022	BUY	$3.27 - $6.38 $13 - $25	4 Added 2.84%	145 $1,000
Q3 2021 Nov 15, 2021	BUY	$5.11 - $10.81 $250 - $529	49 Added 53.26%	141 $1,000
Q1 2021 May 13, 2021	SELL	$2.51 - $6.96 $2 - $6	-1 Reduced 1.08%	92 $1,000
Q4 2020 Feb 09, 2021	BUY	$2.15 - $11.17 $199 - $1,038	93 New	93 $0

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.